These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33829065)

  • 1. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
    Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
    Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
    Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
    Hu LT; Deng WJ; Chu ZS; Sun L; Zhang CB; Lu SZ; Weng JR; Ren QS; Dong XY; Li WD; Li XB; Du YT; Li Y; Wang WQ
    BMC Pulm Med; 2022 Jun; 22(1):259. PubMed ID: 35768814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.
    Zhou Q; Mei YD; Yang HJ; Tao YL
    Future Oncol; 2021 May; 17(15):1889-1906. PubMed ID: 33728938
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
    Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
    Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer.
    Li JY; Li CJ; Lin LT; Tsui KH
    Cancer Control; 2020; 27(1):1073274820976671. PubMed ID: 33297760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles and prognostic values of BolA family members in ovarian cancer.
    Zhu M; Xiao S
    J Ovarian Res; 2021 Jun; 14(1):75. PubMed ID: 34078439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics.
    Dong C; Tian X; He F; Zhang J; Cui X; He Q; Si P; Shen Y
    J Ovarian Res; 2021 Jul; 14(1):92. PubMed ID: 34253236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.
    Chen B; Gao C; Wang H; Sun J; Han Z
    Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment.
    Wu Z; Zhang Y; Chen X; Tan W; He L; Peng L
    Front Mol Biosci; 2020; 7():601206. PubMed ID: 33324682
    [No Abstract]   [Full Text] [Related]  

  • 18. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
    Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
    BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
    Gong G; Lin T; Yuan Y
    J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
    Xu HH; Gan J; Xu DP; Li L; Yan WH
    Front Immunol; 2021; 12():614773. PubMed ID: 34276642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.